Vesicular transport of Charcot-Leyden crystal protein in tumor-promoting phorbol diester-stimulated human basophils

Laboratory Investigation

Volumn 74, Issue 5, 1996, Pages 967-974

  Dvorak, Ann M ^a   Ackerman, Steven J ^a   Letourneau, Linda ^a   Morgan, Ellen S ^a   Lichtenstein, Lawrence M ^b   MacGlashan Jr , Donald W ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CHARCOT LEYDEN CRYSTAL PROTEIN; HISTAMINE; IMMUNOGLOBULIN E; PHORBOL ESTER; UNCLASSIFIED DRUG;

ARTICLE; BASOPHIL DEGRANULATION; CONTROLLED STUDY; CYTOPLASM VESICLE; EXOCYTOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; TUMOR PROMOTION;

BASOPHILS; BIOLOGICAL TRANSPORT; CELL DEGRANULATION; CRYSTALLIZATION; CYTOPLASMIC GRANULES; GLYCOPROTEINS; HISTAMINE RELEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYSOPHOSPHOLIPASE; MICROSCOPY, IMMUNOELECTRON; TETRADECANOYLPHORBOL ACETATE;

EID: 0029972088     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, and Tenen DG (1993). Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase): Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol 150:456-468.
2. Ackerman SJ, Weil GJ, and Gleich GJ (1982). Formation of Charcot-Leyden crystals by human basophils. J Exp Med 155:1597-1609.
3. Barondes SH, Cooper DNW, Gitt MA, and Leffler H (1994). Galectins: Structure and function of a large family of animal lectins. J Biol Chem 269:20807-20810.
4. Dagher SF, Wang JL, and Patterson RJ (1995). Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci USA 92:1213-1217.
5. Dvorak AM (1992). Basophils and mast cells: Piecemeal degranulation in situ and ex vivo - A possible mechanism for cytokine-induced function in disease. In: Coffey RG, editor. Granulocyte responses to cytokines: Basic and clinical research. New York: Marcel Dekker, 169-271.
6. Dvorak AM (1993). Ultrastructural analysis of anaphylactic and piecemeal degranulation of human mast cells and basophils. In: Foreman JC, editor. Immunopharmacology of mast cells and basophils. In: Page C, series editor. The handbook of immunopharmacology. London: Academic Press, 89-113.
7. Dvorak AM (1995). Ultrastructural evidence for vesicular transport in basophil secretion. Fundam Clin Immunol 3:17-28.
8. Dvorak AM and Ackerman SJ (1989). Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils. Lab Invest 60:557-567.
9. Dvorak AM, Letourneau L, Login GR, Weller PF, and Ackerman SJ (1988). Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils. Blood 72:150-158.
10. Dvorak AM, MacGlashan Jr DW, Morgan ES, and Lichtenstein LM (1995b). Histamine distribution in human basophil secretory granules undergoing FMLP-stimulated secretion and recovery. Blood 86:3560-3566.
11. Dvorak AM, Mihm MC Jr, and Dvorak HF (1976). Degranulation of basophilic leukocytes in allergie contact dermatitis reactions in man. J Immunol 116:687-695.
12. Dvorak AM, Morgan ES, Lichtenstein LM, and MacGlasham DW Jr (1994). Activated human basophils contain histamine in cytoplasmic vesicles. Int Arch Allergy Immunol 105:8-11.
13. Dvorak AM, Morgan ES, Schleimer RP, and Lichtenstein LM (1993). Diamine oxidase-gold labels histamine in human mast-cell granules: A new enzyme-affinity ultrastructural method. J Histochem Cytochem 41:787-800.
14. Dvorak AM, Newball HH, Dvorak HF, and Lichtenstein LM (1980). Antigen-induced IgE-mediated degranulation of human basophils. Lab Invest 43:126-139.
15. Dvorak AM, Warner JA, Fox P, Lichtenstein LM, and MacGlasham DW Jr (1995a). Recovery of human basophils after FMLP-stimulated secretion. Clin Exp Allergy 26:281-294.
16. Dvorak AM, Warner JA, Kissell S, Lichtenstein LM, and MacGlasham DW Jr (1991). F-Met peptide-induced degranulation of human basophils. Lab Invest 64:234-253.
17. Dvorak AM, Warner JA, Morgan E, Kissell-Rainville S, Lichtenstein LM, and MacGlasham DW Jr (1992). An ultrastructural analysis of tumor-promoting phorbol diester-induced degranulation of human basophils. Am J Pathol 141:1309-1322.
18. Dvorak HF, Mihm Jr MC, Dvorak AM, Johnson RA, Manseau EJ, Morgan E, and Colvin RB (1974). Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest 31:111-130.
19. Frigeri LG, Zuberi RI, and Liu F-T (1993). ∈BP, a β-galactoside-binding animal lectin, recognizes IgE receptor (Fc∈RI) and activates mast cells. Biochemistry 32:7644-7649.
20. Hecker E (1968). Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae. Cancer Res 28:2338-2349.
21. Hirata F and Axelrod J (1980). Phospholipid methylation and biological signal transmission. Science 209:1082-1090.
22. Kennerly DA, Sullivan TJ, and Parker CW (1979). Activation of phospholipid metabolism during mediator release from stimulated rat mast cells. J Immunol 122:152-159.
23. Leonidas DD, Elbert BL, Zhou Z, Leffler LI, Ackerman SJ, and Acharya KR (1995). Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Structure 3:1379-1393.
24. Levine L and Ohuchi K (1978). Retinoids as well as tumour promoters enhance deacylation of cellular lipids and prostaglandin production in MDCK cells. Nature 276:274-275.
25. Mufson RA, DeFeo D, and Weinstein IB (1979). Effects of phorbol ester tumor promoters on arachidonic acid metabolism in chick embryo fibroblasts. Mol Pharmacol 16:569-578.
26. Schleimer RP, Gillespie E, Daiuta R, and Lichtenstein LM (1982). Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. II. Interaction with other stimuli. J Immunol 128:136-140.
27. Schleimer RP, Gillespie E, and Lichtenstein LM (1981). Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response. J Immunol 126:570-574.
28. Siraganian RP (1974). An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 57:383-394.
29. Truong M-J, Gruart V, Liu FT, Prin L, Capron A, and Capron M (1993). IgE-binding molecules (Mac-2/∈BP) expressed by human eosinophils: Implication in IgE-dependent eosinophil cytotoxicity. Eur J Immunol 23:3230-3235.
30. Van Duuren BL (1969). Tumor-promoting agents in two-stage carcinogenesis. Prog Exp Tumor Res 11:31-68.
31. Warner JA, Peters SP, Lichtenstein LM, Hubbard W, Yancey KB, Stevenson HC, Miller PJ, and MacGlasham DW Jr (1989). Differential release of mediators from human basophils: Differences in arachidonic acid metabolism following activation by unrelated stimuli. J Leukocyte Biol 45:558-571.
32. Warner JA, Reshef A, and MacGlashan DW Jr (1987). A rapid Percoll technique for the purification of human basophils. J Immunol Methods 105:107-110.
33. Weller PF, Bach DS, and Austen KF (1984). Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). J Biol Chem 259:15100-15105.
34. Zhou Z-Q, Tenen DG, Dvorak AM, and Ackerman SJ (1992). The gene for human eosinophil Charcot-Leyden crystal protein directs expression of lysophospholipase activity and spontaneous crystallization in transiently transfected COS cells. J Leukoc Biol 52:588-595.